Tag: market conditions

INDIANAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG) announced today the release of its annual Corporate Responsibility Report, which provides a comprehensive overview of the Company’s strategy and initiatives regarding corporate responsibility practices and policies. The report also details progress, measurements, and case studies around the Company’s goals and related operations.

CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that it intends to offer shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock in a public offering. All of the securities to be sold in the offering are to be offered by Reviva. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Kursat Kacira, the Chairman and President (the “Acquiror”) of Altai Resources Inc. (“Altai” or the “Company”), announced today that he has acquired a direct ownership of 373,843 common shares of the Company (the “Acquisition”), representing approximately 0.7% of the total issued and outstanding shares of the Company (the “Shares”). Prior to the Acquisition, the Acquiror directly owned 9,726,157 Shares, representing approximately 17.4% of the total issued and outstanding Shares, and indirectly owned 1,000,000 Shares, representing approximately 1.8% of the total issued and outstanding Shares. After giving effect to the Acquisition, the Acquiror has a combined direct and indirect ownership of 11,100,000 Shares, representing approximately 19.8% of the total issued and outstanding Shares. These shares are held for investment purposes.

DOGP Holdings Set to Double to 4.02 Billion DOG

Report details record spending, rising bitumen output, and significant increase in Alberta’s oil and gas reserves estimates

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

Partnership with leading robotic lawn mower developer marks strategic diversification beyond automotive intelligence sector

SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the pricing of an underwritten public offering of 7,954,546 shares of its common stock at a price to the public of $44.00 per share. All of the shares are to be sold by Cidara.

LONG BEACH, Calif. and TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., announces that, at the Company's annual and special meeting (the "Meeting") of shareholders that was held on June 20, 2025 at 11:00 a.m. (Pacific Time), the Company's shareholders passed all of the resolutions put before them.